← Benchmark 2024-V10 Mortgage Trust · Loan annex · CMBS market
- Deal
- Benchmark 2024-V10 Mortgage Trust
- Current balance
- $73.5M (September 2026)
- Share of deal
- 10.0%
- Status
- Current
- DSCR (latest)
- not yet reported
- Occupancy (latest)
- not yet reported
- Scheduled maturity
- 2029-08-09
Property and terms
| Property | 200 Sidney (and 7 more properties) |
| Address | 200 Sidney Street; 200, 300, 400, 500 and 800 Lincoln Centre Drive; 40 Erie Street; 4570 Executive Drive; 9360-9390 Towne Centre Drive; 21 Erie Street; 47 Erie Street; 4575 Eastgate Mall; Cambridge, MA (and 7 more) 02139 |
| Property type | Multiple property types |
| Units, beds or keys | 447 |
| Net rentable square feet | not yet reported |
| Year built | not yet reported |
| Year last renovated | ["2016", "2015", "2019", "2020", "2018", "2020"] |
| Original balance | $73.5M |
| Current balance | $73.5M (September 2026) |
| Share of deal balance | 10.0% |
| Interest rate at origination | 5.49% |
| Current interest rate | 5.49% |
| Origination date | 08-09-2024 |
| Original term | 60 months |
| Amortization term | not yet reported |
| Interest-only period | 60 months |
| Scheduled maturity | 2029-08-09 |
| Prepayment lockout end | not yet reported |
| Yield maintenance end | 02-08-2029 |
| Servicer | KeyBank National Association |
| Loan servicer | not yet reported |
| Originator | Citi Real Estate Funding Inc., Goldman Sachs Bank USA |
| Current status | Current |
| Specially serviced now | No |
| Defeased | No |
Valuation
| Basis | Amount | Date | Source (as filed) |
|---|---|---|---|
| At securitization | $1.10B | not yet reported | not yet reported |
| Most recent reported | not yet reported | not yet reported | ["MAI", "MAI", "MAI", "MAI", "MAI", "MAI", "MAI", "MAI"] |
Largest tenants
| Tenant | Square feet | Lease expiration |
|---|---|---|
| AbbVie Inc. | not yet reported | ["07-31-2028", "01-15-2033", "09-30-2026", "06-30-2030", "12-31-2029", "11-30-2030", "12-31-2029"] |
| Seres Therapeutics, Inc. | not yet reported | ["01-13-2030", "09-30-2028", "08-20-2026", "06-30-2030", "11-30-2030"] |
| Intellia Therapeutics, Inc | not yet reported | ["09-30-2026", "04-30-2025", "09-12-2030"] |
The three largest tenants as reported in the latest asset-level record.
Monthly history
| Month | Balance | Status | Rate | DSCR (NCF) | DSCR (NOI) | Occupancy | Advances | Financial period end | Revenue | Expenses | NOI | NCF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| September 2024 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| October 2024 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| November 2024 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| December 2024 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| January 2025 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| February 2025 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| March 2025 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| April 2025 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| May 2025 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| June 2025 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| July 2025 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| August 2025 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| September 2025 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| October 2025 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| November 2025 | $73.5M | Current | 5.49% | 2.29 | 2.30 | 100% | $0 | 06-30-2025 | $98.5M | $28.6M | $69.9M | $69.3M |
| December 2025 | $73.5M | Current | 5.49% | 2.29 | 2.30 | 100% | $0 | 06-30-2025 | $98.5M | $28.6M | $69.9M | $69.3M |
| January 2026 | $73.5M | Current | 5.49% | 2.29 | 2.30 | 100% | $0 | 06-30-2025 | $98.5M | $28.6M | $69.9M | $69.3M |
| February 2026 | $73.5M | Matured balloon, non-performing | 5.49% | not yet reported | not yet reported | not yet reported | $347,161 | ["06-30-2025", "09-30-2025"] | not yet reported | not yet reported | not yet reported | not yet reported |
| March 2026 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | ["06-30-2025", "09-30-2025"] | not yet reported | not yet reported | not yet reported | not yet reported |
| April 2026 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | ["06-30-2025", "09-30-2025"] | not yet reported | not yet reported | not yet reported | not yet reported |
| May 2026 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| June 2026 | $73.5M | Matured balloon, non-performing | 5.49% | not yet reported | not yet reported | not yet reported | $347,161 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| July 2026 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| August 2026 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| September 2026 | $73.5M | Current | 5.49% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
Revenue, expenses, net operating income (NOI) and net cash flow (NCF) are the most recent financials reported as of each month, for the financial period ending on the date shown. DSCR is debt service coverage on the net cash flow and net operating income bases as reported.
Also filed in other trusts
Loans are sometimes split across trusts (pari passu), and each trust files the loan at its whole-loan amount. A loan with the same property name and origination date is filed in: BBCMS Mortgage Trust 2024-5C29; BBCMS Mortgage Trust 2024-5C29.
Sources: SEC Form ABS-EE asset-level reports for the deal. Definitions are in the methods note on the market page.